Civica, Inc.
28 drugs in NADAC|28 Generic,0 Brand
Civica, Inc. lists 28 NDCs in the CMS NADAC file (28 generic, 0 brand), at an average NADAC of $3.63 per unit, with a week-over-week move of +1.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
28
28G / 0B
Avg Price / Unit
$3.6348
$0.18 – $28.77
Avg 7d Change
+1.28%
Across 20 drugs with changes
7d Activity
of 28 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Fentanyl Citrate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Opioid Agonist therapeutic class
Review the broader class where Civica, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Civica, Inc. make?
Civica, Inc. lists 28 NDCs in the CMS NADAC file — 28 generic and 0 brand products.
What is the average price of Civica, Inc. drugs?
The average NADAC across Civica, Inc.'s portfolio is $3.6348 per unit, ranging from $0.1759 to $28.7741.
What types of drugs does Civica, Inc. make?
Civica, Inc. makes drugs across 21 FDA pharmacologic classes. The most common by NDC count are Opioid Agonist (3), Lipopeptide Antibacterial (2), Penem Antibacterial (2), Penicillin-class Antibacterial (2), Benzodiazepine (2).
Has Civica, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Civica, Inc. in the openFDA feed.
How has Civica, Inc.'s pricing changed recently?
Over the past 7 days, 13 Civica, Inc. products rose and 7 fell, with a portfolio-wide average change of +1.3%.